At a glance
ClinicalIndex Comparison RecordN/ACompleted· 143 enrolled
Drug / intervention
SARS-CoV2 serum antibody testingother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Hospital for Special Surgery COVID-19 Antibody Serology Among Anesthesiologists and Surgeons 2020
In Brief
A clinical study evaluating SARS-CoV2 serum antibody testing for COVID. Completed, enrolled 143 participants across 1 site.
Detailed Summary
The goal of this study is to understand the infectious exposure of SARS-coronavirus 2 (SARS-CoV2) among surgeons and anesthesiologists and to correlate this status with self-reported indices of COVID-19 illness.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCOVID
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
202120222023202420252026
Enrollment StartMay 2020
First PostedMay 2020
Primary CompletionJun 2020
Study CompletionSep 2020
TodayJul 2026
First PostedMay 15, 2020
Enrollment StartMay 5, 2020
Primary CompletionJun 16, 2020
Study CompletionSep 4, 2020
TodayJul 2, 2026
Enrollment to primary: 1 monthPosted 6.1 years ago
Interventions
SARS-CoV2 serum antibody testingother
Participants will have SARS-CoV2 serum antibody testing performed twice within 4 months of each other.